| Neurodegenerative disease NN Parayath, G Pawar, C Avachat, MM Miyake, B Bleier, MM Amiji Nanomedicine for Inflammatory Diseases, 289-318, 2017 | 11* | 2017 |
| Preferential formulation of second generation antipsychotic asenapine as inclusion complex with sulphobutylether-βCD (Captisol): in vitro and In vivo evaluation JA Kulkarni, AM Avachat, CM Avachat, R Pradhan, TS Suryawanshi, ... Current drug delivery 15 (4), 520-531, 2018 | 10 | 2018 |
| Management of anti-seizure medications during pregnancy: advancements in the past decade C Avachat, JM Barry, X Lyu, CM Sherwin, AK Birnbaum Pharmaceutics 14 (12), 2733, 2022 | 7 | 2022 |
| Pharmacokinetics of l-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension CD Fike, C Avachat, AK Birnbaum, JL Aschner, CM Sherwin Pediatric Drugs 25 (1), 87-96, 2023 | 5 | 2023 |
| Women of childbearing age: What antiseizure medications are they taking? C Avachat, AK Birnbaum British journal of clinical pharmacology 89 (1), 46, 2023 | 1 | 2023 |
| In vitro evaluation of cationic liposomal delivery of BDNF expressing plasmid DNA in experimental model of Parkinson’s disease C Avachat Northeastern University, 2017 | 1 | 2017 |
| Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia CD Fike, JL Aschner, C Avachat, AK Birnbaum, CMT Sherwin Journal of Perinatology 44 (2), 280-287, 2024 | | 2024 |
| ASCPT Member Profiles EG Berglund, D Boulton, C Avachat, JA Sprowl CLINICAL PHARMACOLOGY & THERAPEUTICS 114 (6), 1162-1163, 2023 | | 2023 |
| Characterization of the US Food and Drug Administration Post‐Marketing Commitments and Requirements for Pregnancy and Lactation C Avachat, IR Younis, AK Birnbaum Clinical Pharmacology & Therapeutics 114 (6), 1238-1242, 2023 | | 2023 |
| Changes in total daily dose of lamotrigine and levetiracetam during pregnancy: reflection on current clinical practice at US tertiary epilepsy centers C Avachat, AK Birnbaum, PB Pennell, KJ Meador EPILEPSIA 64, 93-94, 2023 | | 2023 |
| Pharmacokinetics and safety of prolonged paracetamol treatment in neonates: An interventional cohort study S Haslund‐Krog, JM Barry, AK Birnbaum, K Dalhoff, T Brink Henriksen, ... British Journal of Clinical Pharmacology 89 (11), 3421-3431, 2023 | | 2023 |
| Characterization of lacosamide pharmacokinetics in older adults with epilepsy (P4-1.007) C Avachat, S Reeder, Y Long, I Leppik, S Patel, A Birnbaum Neurology 100 (17 Supplement 2), 2023 | | 2023 |
| Exploring the past to inform the future to optimize the pharmacokinetics of vancomycin in children with severe burn injuries CM Sherwin, NK Tran, K Sullivan, S Wead, AK Birnbaum, C Avachat, ... Journal of Burn Care & Research 44 (2), 353-362, 2023 | | 2023 |
| Maternal Symptomatic Toxicity and Oxcarbazepine Free Fraction during Pregnancy in Women with Epilepsy (S13. 008) P Pennell, A Birnbaum, C Avachat, S Hwang, L Kalayjian, E Gerard, ... Neurology 98 (18 Supplement), 2022 | | 2022 |
| Maternal and Umbilical Cord Plasma Concentrations of Antiseizure Medications: Results from the MONEAD Study Charul Avachat, Evan Gedzelman, Abigail Mathews, Thomas McElrath, Angela ... American Epilepsy Society, https://cms.aesnet.org/abstractslisting/, 2021 | | 2021 |
| Characterization of lamotrigine dosing scenarios when co-prescribed with combined oral contraceptives C Avachat, A Karanam, P Pennell, A Pack, A Davis, AK Birnbaum American Epilepsy Society, 2020 | | 2020 |
| Formulation and In Vitro Transfection Studies with Brain Derived Neurotrophic Factor Expressing Plasmid DNA Encapsulated in Cationic Liposomes C Avachat, MM Amiji 2017 Controlled Release Society Annual Meeting, 2017 | | 2017 |
